Verition Fund Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53,585
| Closed | -$88.4K | – | 2722 |
|
|
2024
Q4 | $88.4K | Buy |
+53,585
| New | +$88.4K | ﹤0.01% | 2425 |
|
|
2024
Q3 | – | Sell |
-36,675
| Closed | -$120K | – | 2564 |
|
|
2024
Q2 | $120K | Buy |
+36,675
| New | +$120K | ﹤0.01% | 2057 |
|
|
2023
Q4 | – | Sell |
-52,654
| Closed | -$112K | – | 1983 |
|
|
2023
Q3 | $112K | Buy |
+52,654
| New | +$112K | ﹤0.01% | 1752 |
|
|
2023
Q1 | – | Sell |
-12,744
| Closed | -$129K | – | 2013 |
|
|
2022
Q4 | $129K | Buy |
+12,744
| New | +$129K | ﹤0.01% | 1418 |
|
|
2021
Q4 | – | Sell |
-12,755
| Closed | -$756K | – | 1940 |
|
|
2021
Q3 | $756K | Sell |
12,755
-9,156
| -42% | -$543K | 0.01% | 818 |
|
|
2021
Q2 | $1.9M | Buy |
+21,911
| New | +$1.9M | 0.02% | 461 |
|